Recurrent Endometrial Cancer Recruiting Phase 2 Trials for DB12167 (LY-3023414)

Also known as: Endometrial cancer recurrent / Cancer of endometrium recurrent / Ca endometrium recurrent / Endometrial carcinoma recurrent / Carcinoma endometrial recurrent

IndicationStatusPhase
DBCOND0054384 (Recurrent Endometrial Cancer)Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02549989Study of LY3023414 for the Treatment of Recurrent or Persistent Endometrial CancerTreatment